Transfusion - Pre-compatibility Testing —
Training activity: 5

Details

Perform appropriate further testing, reporting and/or referral for unresolved antibody identifications

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Impact of recent transfusions, treatments and therapeutics on patient sample acceptance and algorithms
• Emerging therapeutics, including novel monoclonal antibodies
• Other causes (inc. Technique dependent)
• Phenotyping or genotyping requirements

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What are the current guidelines and laboratory policies regarding further investigation of unresolved antibody identifications?
• What specific further testing methodologies might be required (e.g., enzyme treatment, neutralisation)? What are the principles behind these tests?
• What are the criteria for reporting complex antibody identifications?
• What is the local referral pathway for cases that cannot be resolved within the laboratory? What information needs to be included in a referral?
• Consider the specific insights you hope to gain regarding the practical application of further antibody identification techniques.
• Think about what you already know about antibody identification and where your knowledge gaps might be in handling unresolved cases.
• Review relevant standard operating procedures (SOPs) and national guidelines related to complex antibody investigations and referral processes.
• Consider possible challenges you might face during this activity, such as unexpected results or difficulties in interpretation, and think about how you might handle them.

In action

• How are you approaching the further testing required for this unresolved antibody identification? Why are you choosing these specific tests or approaches?
• What decisions are you making as you proceed through the testing? For example, what criteria are you using to select the next test, or when are you deciding to consult a senior colleague?
• How effective are your chosen actions proving to be in identifying the unresolved antibody(ies)?
• What challenges are you facing as you perform the tests or interpret the results (e.g., unexpected reactions, ambiguous patterns)?
• What can you learn from the current results as they unfold? Are they suggesting a particular antibody specificity or a technical issue?
• How does this specific case connect to your existing knowledge and skills in antibody identification? Are you recognising any familiar patterns or encountering something new?
• Are there alternative approaches you could be considering if your initial steps are not providing a resolution (e.g., different enhancement media, cell panels, techniques)?
• What support or guidance might you need in this moment? Would it be beneficial to discuss the case with a senior colleague or refer to a specific guideline?
• Are you working within your scope of practice for performing and interpreting these complex investigations and making decisions about reporting or referral?

On action

• Begin by summarising the key points of the experience.
  • What specific further testing did you perform?
  • What were the key steps you took in the process?
  • What were the final results or outcome (e.g., identification of the antibody, decision to refer)?
  • What were the challenging aspects of this particular unresolved antibody identification?
  • Were there any unexpected reactions or patterns? What aspects of your reflect-in-action (during the activity) influenced how the further testing unfolded? For example, did your initial observations guide your choice of subsequent tests?
• What skills or knowledge did you develop or improve through this activity related to complex antibody identification strategies, techniques, or interpretation of results?
  • Were there any unexpected challenges or successes during the activity?
  • What did you learn from these regarding troubleshooting or effective problem-solving in this context?
  • How does this experience relate to the requirements for post-programme practice in terms of handling complex serological investigations?
• What areas for continued development have been identified as a result of this activity in the realm of unresolved antibody identifications?
  • How can you apply the learning from this specific case to your routine practice when faced with similar challenges?
  • Identify the actions / ‘next steps’ you will now take to support the assimilation of what you have learned, such as reviewing specific protocols, seeking further training, or discussing the case with a senior colleague.
  • What support or resources might you need to further develop in the areas identified through this reflection, such as access to specialist literature or opportunities for further practical experience?

Beyond action

• Have you encountered other cases of unresolved antibody identifications since performing this training activity? Were the approaches to further testing similar or different?
• Have you reviewed your initial reflections (reflect-on-action) for this activity in light of subsequent experiences with complex antibody investigations? What new insights have you gained?
• Consider other training activities where you have had to interpret complex serological results. How do those experiences compare with this one? Have you compared your understanding with peers or colleagues?
• How has this training activity influenced your approach to troubleshooting complex antibody panels or unexpected reactions in pre-transfusion testing?
• Has this experience improved your confidence in deciding when further referral to a specialist centre is necessary?
• Can you identify instances where your understanding gained from this training activity has helped you interpret or explain complex serological results to colleagues or clinical staff?
• How will your experience with unresolved antibody identifications prepare you for more complex cases or the introduction of new diagnostic techniques in the future?
• Will your ability to critically evaluate and manage such cases be a valuable asset in ensuring the provision of safe blood for patients with complex serological profiles?
• How might this experience support your potential involvement in developing or reviewing local guidelines for managing unresolved antibody identifications?

 

Relevant learning outcomes

#	Outcome
# 1	Outcome Select suitable and valid techniques for transfusion pre-compatibility testing.
# 2	Outcome Identify sequential testing algorithms appropriate to the samples under investigation for pre-compatibility testing.
# 3	Outcome Describe the limitations of methods used in pre-compatibility testing including sources of error and sample issues.
# 4	Outcome Practice in accordance with guidelines and procedures relevant to pre-transfusion testing.
# 5	Outcome Perform acceptance testing of samples requiring pre-transfusion testing and ensure samples follow appropriate testing streams relating to clinical condition.
# 6	Outcome Perform phenotyping and/or referral of genotyping to complete investigation for pre-transfusion testing.
# 8	Outcome Devise and perform investigative strategies for complex antibody identifications and transfusion reaction investigations.